combination therapy comprising a cdk4 / 6 inhibitor and a pi3k inhibitor for use in cancer treatment
- 专利权人:
- NOVARTIS AG
- 发明人:
- ALAN XIZHONG HUANG,KRISTY HAAS,SHIVANG DOSHI,STEVEN KOVATS,SUNKYU KIM,YAN CHEN
- 申请号：
- BR112013033940
- 公开号：
- BR112013033940A2
- 申请日:
- 2012.07.02
- 申请国别(地区):
- BR
- 年份:
- 2017
- 代理人:
- 摘要：
- A combination of a CDK4/6 inhibitor and a P3Kinase inhibitor for the treatment of cancer.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- COMBINATION THERAPY COMPRISING A CDK4/6 INHIBITOR AND A PI3K INHIBITOR FOR USE IN THE TREATMENT OF CANCER
- COMBINATION THERAPY COMPRISING A CDK4/6 INHIBITOR AND A PI3K INHIBITOR FOR USE IN THE TREATMENT OF CANCER
- Combination Therapy Comprising A CDK4/6 Inhibitor and a P13K Inhibitor for Use in the Treatment of Cancer
- Combination Therapy Comprising A CDK4/6 Inhibitor and a PI3K Inhibitor for Use in the Treatment of Cancer
- COMBINATION THERAPY COMPRISING A CDK4/6 INHIBITOR AND A P13K INHIBITOR FOR USE IN THE TREATMENT OF CANCER
